Genus (LSE:GNS) Research & Development: £0.0 Mil (TTM As of Dec. 2025)


LSE:GNS Genus PLC LSE:GNS
75 GF Score
Price £21.58
GF Value £20.62
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Genus Research & Development?

Genus LSE:GNS +1.22% 75 Research & Development is £0.0 Mil as of Dec. 2025. GuruFocus rates LSE:GNS with a GF Score™ of 75/100 and a GF Value™ of £20.62 (Fairly Valued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Genus's Research & Development for the six months ended in Dec. 2025 was £0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was £0.0 Mil.

Genus  (LSE:GNS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Genus Research & Development Related Terms

Genus Research & Development Historical Data

* Premium members only.

The historical data trend for Genus's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genus Research & Development Chart

Genus Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.20 5.60 31.00 27.80 21.70

Genus Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LSE:GNS
75GF Score
Genus PLC LSE:GNS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genus Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.0 Mil mean?
Genus (LSE:GNS) has a Research & Development of £0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Genus and its competitors.
Is Genus' Research & Development too high?
Genus' current Research & Development is £0.0 Mil. Overall, Genus has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genus' Research & Development compare to VRTX and REGN?
Genus' Research & Development of £0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Genus and its competitors. Genus's current Research & Development is £0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genus stock overvalued right now?
Based on GuruFocus' analysis, Genus (LSE:GNS) is currently considered Fairly Valued. The stock's GF Value™ is £20.62, compared to a current price of £21.58 — trading 4.7% above its estimated fair value. The current Research & Development is £0.0 Mil. Genus' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Genus (LSE:GNS), the current Research & Development is £0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genus (LSE:GNS) Overvalued in 2026?

Based on GuruFocus' analysis, Genus stock appears to be overvalued. The current stock price of £21.58 is trading 4.7% above its estimated GF Value™ of £20.62. GuruFocus considers Genus to be Fairly Valued.

Key valuation signals for LSE:GNS:

  • Research & Development: £0.0 Mil
  • GF Value™: £20.62 vs. price of £21.58 (4.7% above fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the LSE:GNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genus Business Description

Address Matrix House, Basing View, Basingstoke, Hampshire, GBR, RG21 4FF
Genus PLC is an animal genetics company focused on improving cattle and pig populations to support sustainable food production. The company operates through two main business units: one providing bovine genetics mainly for dairy and beef cattle, and the other offering porcine genetics for pork production. Genus develops genetically superior breeding animals using scientific techniques. It generates revenue by selling genetics, including semen and embryos, as well as through related services under multi-year royalty agreements. The principal activities of each segment are: (a) Genus PIC porcine sales business, (b) Genus ABS: bovine sales business, and (c) Genus Research and Development: spending on research and development.
75GF Score

Get the complete analysis for LSE:GNS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£21.58
Price
£20.62
GF Value